Note: Ingredients listed on restricted chemical lists
EC/CAS
8032-32-4
Name of the chemical
Ligroine
Concentration
1-5
General Information
Revision date
2010-10-29
Product name
HIGH PERFORMANCE REDUCER FAST
1.2.1 Relevant identified uses
For additional information call our the Akzo Nobel Car Refinishes Techline at 1-800-618-1010
Manufacturer Name
Canadian Supplier
Emergency telephone
(HEALTH OR SPILLS
Icons in SDS
Company Information
company name
Akzo Nobel Coatings Inc
GHS Information
Signal word
WARNING!
Section 2
SECTION 2: Hazards identification
Emergency overview WARNING! FLAMMABLE LIQUID AND VAPOR. CAUSES RESPIRATORY TRACT, EYE AND SKIN IRRITATION. MAY BE HARMFUL IF ABSORBED THROUGH SKIN OR IF SWALLOWED. CONTAINS MATERIAL THAT CAN CAUSE TARGET ORGAN DAMAGE. POSSIBLE CANCER HAZARD - CONTAINS MATERIAL WHICH MAY CAUSE CANCER, BASED ON ANIMAL DATA. POSSIBLE BIRTH DEFECT HAZARD - CONTAINS MATERIAL WHICH MAY CAUSE BIRTH DEFECTS, BASED ON ANIMAL DATA.
Potential Acute Health Effects
Inhalation Irritating to respiratory system. Ingestion Harmful if swallowed. Skin Harmful in contact with skin. Severely irritating to the skin. Eyes Irritating to eyes.
Potential chronic health
effects : Contains material that can cause target organ damage. Carcinogenicity : Contains material which may cause cancer, based on animal data. Risk of cancer depends on duration and level of exposure. Mutagenicity : No known significant effects or critical hazards.
Teratogenic Effects
Contains material which may cause birth defects, based on animal data. Developmental effects : No known significant effects or critical hazards. Fertility effects : No known significant effects or critical hazards. Target organs : Contains material which causes damage to the following organs: upper respiratory tract, skin, central nervous system (CNS), eye, lens or cornea. Contains material which may cause damage to the following organs: blood, kidneys, liver, gastrointestinal tract. Over-exposure signs/symptoms Inhalation : Adverse symptoms may include the following: respiratory tract irritation coughing Ingestion : No specific data. Skin : Adverse symptoms may include the following: irritation redness Eyes : Adverse symptoms may include the following: pain or irritation watering redness Medical conditions Pre-existing disorders involving any target organs mentioned in this MSDS as being at aggravated by over- risk may be aggravated by over-exposure to this product. exposure NOTICE: Reports have associated repeated and prolonged OVEREXPOSURE to solvents with permanent brain and nervous system damage. Intentional misuse by deliberately concentrating and inhaling the contents of this package may be harmful or fatal. See toxicological information (section 11)